Type III-A CRISPR-Cas systems employ the Cas10-Csm complex to destroy bacteriophages and plasmids, using a guide RNA to locate complementary RNA molecules from the invader and trigger an immune response that eliminates the infecting DNA. In addition, these systems possess the non-specific RNase Csm6, which provides further protection for the host. While the role of Csm6 in immunity during phage infection has been determined, how this RNase is used against plasmids is unclear. Here, we show that Staphylococcus epidermidis Csm6 is required for immunity when transcription across the plasmid target is infrequent, leading to impaired target recognition and inefficient DNA degradation by the Cas10-Csm complex. In these conditions, Csm6 causes growth arrest in the host and prevents further plasmid replication through the indiscriminate degradation of host and plasmid transcripts. In contrast, when plasmid target sequences are efficiently transcribed, Csm6 is dispensable and DNA degradation by Cas10 is sufficient for anti-plasmid immunity. Csm6 therefore provides robustness to the type III-A CRISPR-Cas immune response against difficult targets for the Cas10-Csm complex.
I n prokaryotes, clustered regularly interspaced short palindromic repeats (CRISPR) loci provide defence against parasitic phages 1 and plasmids 2 . Defence is mediated by the acquisition of short 'spacer' sequences (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) nucleotides) from the invading phage or plasmid during infection, which are inserted between the CRISPR repeats. Spacers are then transcribed and processed into CRISPR RNAs (crRNAs), which guide CRISPR-associated (Cas) nucleases to the target of the invader (known as the protospacer) through complementary base pairing [3] [4] [5] [6] and trigger its destruction.
To date, six major types of CRISPR systems have been identified, which vary in their cas gene composition and mechanism of action 7 . Type III systems are uniquely able to degrade both the DNA and RNA of the invader 8 . The Cas10-Csm (type III-A) and Cas10-Cmr (type III-B) complexes use crRNA guides to detect and anneal to transcripts harbouring a complementary sequence 4, [9] [10] [11] . This base pair interaction unleashes the single-stranded DNase activity of Cas10 [12] [13] [14] and the sequence-specific RNase activity of Csm3 9, 10, 15 or Cmr4 4, 11 . DNA degradation by Cas10 is transient, and cleavage of the protospacer RNA by Csm3 or Cmr4 results in Cas10 inactivation and the dissociation of the effector complex from its target [12] [13] [14] .
In addition to the Cas10 complexes, type III systems use an accessory RNase, Csm6 for type III-A and Csx1 for type III-B 16 . Csm6 is an endoribonuclease 17 whose activity is modulated by cyclic oligoadenylate (cOA), a second messenger synthesized by the Palm domain of Cas10 following target recognition by the crRNA [18] [19] [20] . The deactivation of Csm6 is the consequence of the two following events: (1) the lack of synthesis of new cOA molecules by the Palm domain after cleavage of the target transcript by Csm3 or Cmr4 [19] [20] [21] , and (2) the degradation of the existing cOA, presumably by specific ring nucleases 22 .
In studies of the function of Csm6 during the type III-A CRISPR-Cas immune response against lambda-like doublestranded DNA phages, it was found that Csm6 RNase activity is required only when the target is transcribed late in the phage life cycle 23 . Because late targeting cannot prevent phage replication, it is hypothesized that Csm6 degradation of viral transcripts prevents the completion of the lytic cycle and allows Cas10 DNase activity to clear the phage genomes that accumulated before the transcription of the target. Csm6 has also been shown to be required for the prevention of plasmid conjugation and plasmid transformation by type III-A CRISPR-Cas systems 24, 25 . However, how Csm6 contributes to plasmid clearance is still not understood. Here, we show that low levels of target transcription are sufficient to activate Csm6 and trigger non-specific degradation of both host and plasmid transcripts. This accelerates plasmid clearance by the Cas10-Csm complex, presumably through the depletion of transcripts required for efficient plasmid replication and maintenance. Simultaneously, the destruction of host transcripts produces growth arrest, as previously proposed 19, 20, 26 . Since plasmid DNA degradation leads to the disappearance of the targets that activate Csm6, the induced growth arrest is short lived and the cells resume normal growth following plasmid clearance. Our study furthers our understanding of the mechanisms by which type III-A CRISPR-Cas systems employ a two-pronged combination of DNase and RNase activities to provide robust immunity against foreign genetic parasites.
Results
Csm6 RNase activity is required for immunity against poorly transcribed targets in pG0400. The spacer spc1 in the CRISPR-cas locus of S. epidermidis RP62A ( Fig. 1a ) targets the nickase (nes) gene of the conjugative plasmid pG0400, preventing pG0400 transfer 2 . However, a northern blot analysis of the crRNAs derived from spc1 indicated that the CRISPR locus is transcribed unidirectionally 27 and that the spc1 crRNA has the same, not the complementary, sequence as the putative transcript of the nes gene. Given the requirement of direct binding between the crRNA guide and a target RNA for type III-A CRISPR-Cas immunity 28, 29 , we performed RNA sequencing (RNA-seq) analyses of pG0400 transcripts to look for the presence of nes antisense transcripts that could elicit the spc1mediated anti-plasmid response. We found very low levels of reads corresponding to transcripts derived from the nes non-template strand, which we hypothesized would result in infrequent activation of the DNase activity of the spc1 crRNA-Cas10-Csm complex. In turn, inefficient clearance of the pG0400 genome would lead to the Csm6 requirement for anti-plasmid immunity that we have reported on previously 25 .
To test this hypothesis, we generated a construct harbouring a reversed spc1 (spc1-flip) that would produce a crRNA complementary to the highly abundant nes transcript ( Fig. 1b ). This was achieved by using Staphylococcus aureus RN4220 30 harbouring a S. epidermidis type III-A CRISPR-cas locus on the chloramphenicol-resistant pC194 staphylococcal plasmid, pCRISPR 25 , with modified spacer sequences. We found that in contrast to spc1, for which targeting requires csm6 25 (Fig. 1c ), spc1-flip blocked pG0400 conjugation in recipients expressing a catalytically dead (R364A, H369A) csm6 version (dcsm6) 17, 23 (Fig. 1c ). We also constructed a pG0400 derivative (pG0420) in which we inserted a strong promoter that drives high transcription of the nes non-template strand ( Fig. 1d ). Next, we tested the ability of spc1 to mediate immunity against pG0420 in the presence or absence of Csm6 RNase activity. We found that similar to spc1-flip, the increased transcription of the target RNA eliminated the Csm6 requirement observed for pG0400 ( Fig. 1c ). Together, these results support our hypothesis that csm6 RNA degradation is not required for plasmid clearance in conditions of high target transcription. We also determined that the other type III-A RNase, Csm3 within the Cas10-Csm complex, is not required for anti-plasmid immunity under low transcription conditions ( Supplementary Fig. 1 ).
Csm6 RNase activity accelerates plasmid clearance in conditions of low target transcription.
To determine how Csm6 affects antiplasmid immunity in the presence of different levels of target transcription, we placed the gp43 protospacer 23 (from phage ф NM1γ 6 29 ) under the control of a tight and tuneable anhydrotetracycline (aTc)inducible promoter 31 , flanked by strong transcriptional terminators (pTarget; Fig. 2a ). We performed northern blotting to validate these useful features of pTarget ( Fig. 2b ). We did not detect target transcript in the absence of aTc, and found that target transcription levels correlated with the aTc concentration. We first investigated the effect of Csm6 on the fate of plasmid DNA. We generated S. aureus cultures harbouring both pTarget and pCRISPR, added different concentrations of aTc, purified the plasmids and visualized them using agarose gel electrophoresis. We found that at high levels of aTc (that is, high target transcription), plasmid loss was equally efficient in wild-type and dcsm6 backgrounds ( Fig. 2c ), even shortly after induction ( Supplementary Fig. 2 ). This result corroborates our previous result, whereby type III-A immunity is independent of Csm6 at high levels of target transcription and that this ribonuclease is not necessary for DNA degradation per se. In contrast, at low levels of aTc, pTarget remained stable in hosts carrying the dcsm6 allele ( Fig. 2d ), demonstrating that the RNase activity of Csm6, which is essential for immunity in these conditions, leads to an accelerated rate of plasmid DNA loss.
Csm6 activation leads to non-specific degradation of host and plasmid transcripts. How can a RNase affect plasmid DNA stability? We used RNA-seq to investigate whether Csm6 was responsible for the degradation of host and/or plasmid transcripts important for plasmid replication and maintenance. Plasmid degradation carried out by the DNA cleavage activity of the type III-A system would lead to differences in transcript abundance due to different plasmid template levels (not only due to Csm6 RNase activity). Therefore, we performed RNA-seq in a cas10 mutant genetic background that lacks DNase activity.
Previously, we reported that the Palm domain of the Cas10 subunit of the type III-A S. epidermidis complex is implicated in DNA cleavage 15 . However, recent work on other type III systems has shown that Cas10 nuclease activity relies on its HD domain [12] [13] [14] 32 and that the Palm domain is involved in the synthesis of the inducer of Csm6, cOA 14, 20, 21 . To clarify this discrepancy, we repeated the experiment shown in Fig. 2c in a genetic background harbouring mutations in the HD domain (H14A, D15A (cas10 HD )) or the Palm domain (D586A, D587A (cas10 Palm )) ( Fig. 1a ). We tested conditions of high target transcription in a dcsm6 background to avoid the interference of RNA degradation in the interpretation of the results. We found that the HD, but not the Palm, domain of Cas10 is required for the clearance of pTarget ( Fig. 2e ); therefore, we used a pCRISPR-cas10 HD mutant for our RNA-seq experiment.
For the RNA-seq experiment, wild-type or dcsm6 cells were collected in duplicate either before or 2 min after induction with a low concentration of aTc. RNA was extracted and sequenced, and the average transcript abundance of every gene at 0 or 2 min after induction was plotted. Host transcripts exhibited a marked decrease in global transcript abundance in the presence of Csm6; that is, most genes Fig. 1 | Csm6 is required for interference against pg0400 when the target is weakly transcribed. a, The S. epidermidis RP62A type III-A CRISPR, with the catalytic residues of Cas10 and Csm6 highlighted. The black boxes, representing repeats, flank the coloured boxes, symbolizing spacers. The spc1 matches the nes antisense transcript of the conjugative plasmid pG0400. b, Genetic structure around the nes protospacer in pG0400, with RNA-seq traces representing read depth. The annealing positions for spc1 and spc1-flip are indicated. RPM, reads per million. c, Conjugation of pG0400 or pG0420 into S. aureus cells containing pCRISPRs with the indicated csm6 variant (wild type (WT) versus catalytically dead (dcsm6)) and spacer after filter mating. Each bar represents the mean of three biological replicates ± s.e.m. d, As for b, but for plasmid pG0420, with the inserted transcriptional promoter shown as a black arrow.
falling below the identity line ( Fig. 3a ). In the absence of the RNase activity of Csm6, however, this reduction was not detected. pTarget transcripts showed a similar difference in abundance ( Fig. 3b ). To corroborate the RNA-seq results, northern blot analysis was performed to detect a subset of transcripts (Fig. 3c ). The transcripts corresponding to the pTarget protospacer, the plasmid replication repF gene and the chromosomal gene def (encoding peptide deformylase) were all rapidly degraded in the presence of Csm6 RNase activity. Together, these experiments demonstrate that Csm6 activation during the type III-A CRISPR-Cas immune response results in significant depletion of both host and plasmid transcripts.
Degradation of host transcripts induces growth arrest. The results described above suggest two hypotheses. The first is that the general destruction of host transcripts should result in host cell toxicity during type III-A CRISPR-Cas immunity. The second is that the degradation of transcripts important for replication and/or maintenance should prevent the replenishment of plasmid DNA, therefore facilitating plasmid clearance by the DNase activity of the Cas10-Csm complex. We tested the first hypothesis by looking at the effect of CRISPR immunity against pTarget on host growth. In the presence of erythromycin, cell survival required the presence of pTarget to provide resistance against the antibiotic, and growth of the culture correlated with the rate of plasmid loss observed in Fig. 2c,d ( Supplementary Fig. 3a,b ). Therefore, to determine whether Csm6 activation results in collateral RNA degradation, we measured the effect of type III-A targeting on culture growth in the absence of erythromycin; that is, without plasmid selection. Under low target transcription conditions that require Csm6 for rapid plasmid loss ( Fig. 2d ; Supplementary Fig. 1b ), we detected significant growth arrest that was dependent on the presence of the RNase activity of Csm6 ( Fig. 4a ). To measure plasmid destruction, we enumerated the cells that still contained pTarget at the end of the growth experiment by counting the erythromycin-resistant (ermR) colony forming units (c.f.u.) that remained after induction ( Fig. 4b ). We found a csm6dependent decrease in c.f.u. that reflected extensive plasmid clearance in the culture. These results show that Csm6 activation, which is required for plasmid loss under low target transcription conditions, is also responsible for generating a growth defect of the host. Interestingly, this growth defect is triggered by the enzymatic activity of Csm6 even in conditions of high transcription, when this RNase is not required for plasmid clearance ( Supplementary Fig. 3c,d ).
Non-specific degradation of host and plasmid transcripts facilitates plasmid clearance. Next, we investigated the second hypothesis: whether the prevention of expression of genes important for plasmid replication could accelerate plasmid clearance. pTarget genes such as repF and cop are important for plasmid replication and maintenance, and our RNA-seq analysis determined that these transcripts are targeted by Csm6. In addition, Csm6-mediated depletion of host transcripts required for plasmid replication, such as DNA polymerase and single-stranded DNA binding protein 33 , could impair plasmid stability and facilitate clearance by the type III-A CRISPR-Cas system. Next, we tested whether a global reduction of gene expression, similar to that caused by Csm6 activation, can accelerate plasmid loss during the type III-A CRISPR-Cas immune response. To this end, we used neomycin, an inhibitor of the 30S ribosomal subunit, and measured pTarget clearance after induction with low levels of aTc. In contrast to the results shown in Fig. 2d , repeating this experiment in the presence of neomycin led to rapid pTarget clearance also in the dcsm6 background ( Fig. 4c ), comparable to that of cells expressing wild-type Csm6. Importantly, neomycin did not affect pTarget stability in non-targeting hosts (Δ spc; Fig. 4c ) or in cells without Cas10 DNase activity ( Supplementary Fig. 4 ). These results support the idea that a reduction in the expression of both plasmid and host genes, either by the non-specific mRNA degradation by Csm6 or by neomycin-induced inhibition of translation, can facilitate the type III-A CRISPR-Cas immunity against plasmids with low rates of protospacer transcription.
Complete plasmid clearance requires DNA cleavage by Cas10. Finally, we examined whether transcript degradation by Csm6 alone Following the addition of the inducer aTc, transcription is initiated from promoter P tet , and the gp43 protospacer is transcribed. This transcription allows interference against pTarget by pCRISPR. The transcriptional terminators prevent non-specific background transcription across the gp43 target. b, Northern blot analysis of pTarget (performed once), detecting the gp43 target transcript before, or 2 min after, addition of either low or high concentrations of aTc. The empty plasmid pE194 was used as a control. c, pTarget plasmid curing assay, whereby plasmid DNA was extracted from cells containing pTarget and a pCRISPR with the specified csm6 allele, before or at the specified time after adding high levels of aTc, and visualized by gel electrophoresis. The gel image is representative of three independent experiments. d, As for c, but with induction of protospacer transcription by low levels of aTc. The gel image is representative of three independent experiments. e, As for c, but with mutations in the Cas10 Palm or HD domains, both in a dcsm6 background. The gel image is representative of three independent experiments.
is sufficient for anti-plasmid type III-A CRISPR-Cas immunity. We measured the growth of cells carrying the cas10 HD mutation after induction of target transcription in the absence of erythromycin selection. We found that the growth arrest was much more severe than detected with wild-type Cas10 (Fig. 4a) , which is probably due to the absence of DNA cleavage and the persistence of pTarget, leading to continuous activation of Csm6 (Fig. 5a ). This growth arrest was dependent on the ability of the Cas10 Palm domain to make cOA and on the RNase activity of Csm6. In addition, all the cells that recovered at the end of the experiment were able to grow on Δ spc is a no spacer control. A 600 measurements were taken every 10 min, each data point represents the mean of three biological replicates ± s.e.m. b, Cells at the end of the experiment in a were spotted onto TSB plates in the presence or absence of erythromycin, selecting for the presence of pTarget, and enumerated. Each bar represents the mean of three biological replicates ± s.e.m. c, Plasmid curing assay, whereby plasmid DNA was extracted from cells harbouring the specified pCRISPR and pTarget, before or at different times after induction of protospacer transcription by the addition of low levels of aTc, and visualized by gel electrophoresis. The cells were grown in the presence of the translational inhibitor neomycin. The gel image is representative of three independent experiments. erythromycin and therefore retained pTarget (Fig. 5b) , escaping arrest through the accumulation of mutations that abrogate type III-A immunity and the activation of Csm6 ( Supplementary Fig. 5 ).
Together, these results demonstrate that the Csm6-mediated nonspecific degradation of host and plasmid transcripts that affect plasmid replication is not sufficient to mount an efficient type III-A CRISPR-Cas immune response, which also requires the destruction of plasmid DNA by the Cas10 nuclease. We also investigated the effect of Csm6-mediated growth arrest on the type III-A immune response against pG0400, the natural plasmid target of the S. epidermidis CRISPR system. Previously, we have shown that mutations in the Palm domain of csm6 and cas10 Palm domain, but not in the HD domain, leads to an increase in the number of pG0400 transconjugants; that is, lack of type III-A immunity 25 . Similar results were recently obtained by analysing this system in an Escherichia coli heterologous host 24 . Given our findings with pTarget, we thought that we might have failed to see pG0400 transconjugants in the cas10 HD background if the Csm6-mediated growth arrest affected colony growth. Therefore, we performed conjugation assays and incubated the plates seeded with transconjugants for a longer time (24 h as opposed to the 16 h used in previous assays). Indeed, we found that cas10 HD hosts do produce a large number of transconjugants, indicating a loss of CRISPR immunity (Fig. 5c,d ). However, transconjugant colonies are markedly small (Fig. 5d ). As we hypothesized, Csm6 is responsible for this phenotype, which was eliminated by the addition of the dcsm6 mutation (cas10 HD compared with cas10 HD /dcsm6; Fig. 5d ). Together, these results with both pTarget and pG0400 suggest that Csm6-mediated growth arrest is only temporary and not essential for type III-A immunity against plasmids. Conversely, Cas10-mediated DNA cleavage is absolutely necessary to fully eliminate the plasmid target and turn off the non-specific RNase activity of Csm6.
Discussion
Here, we showed that Csm6 RNase activity is only required for S. epidermidis type III-A CRISPR-Cas immunity under conditions of low transcription of the plasmid target sequence. We found that activated Csm6 resulted in the non-specific degradation of host and plasmid transcripts and promoted fast clearance of the target plasmid by reducing the expression of genes important for its replication and/or maintenance. In addition, the global depletion of host transcripts led to growth arrest. Csm6 RNase activity was not sufficient for plasmid clearance, and the slow degradation of plasmid DNA by the Cas10 nuclease was also required. Following complete plasmid loss promoted by both activities, the target transcript was eliminated and cOA production ceased (and eventually degraded), resulting in Csm6 deactivation and the return of normal growth. Although our studies only addressed type III-A CRISPR-Cas systems, type III-B systems have a similar targeting mechanism. Therefore, it is likely that their accessory RNase, Csx1 34 , has a similar function to that described here for Csm6.
We believe that when target transcription is low there are few recruitment events of the Cas10-Csm complex to the invading plasmid, and DNA cleavage is inefficient. Under such conditions a 'two-hit punch' is required for immunity, whereby Csm6 prevents the plasmid from replicating while the Cas10-Csm complex slowly degrades the plasmid. This is in line with studies of the type III-A anti-phage response 23 , in which it was found that Csm6 is required when the target is expressed late in the phage lytic cycle. In this case, the accumulation of many phage genomes before the activation of type III-A immunity would overwhelm the DNA cleavage capacity of the Cas10-Csm complex. Csm6-dependent degradation of both host and phage transcripts would hinder phage replication and allow time for the gradual degradation of phage genomes by Cas10. Also, Csm6 was determined to be essential when the phage target contains multiple mismatches with the crRNA guide. It is conceivable that such mismatches will specifically inhibit activation of the HD domain but not the Palm domain, leading to low DNA cleavage but normal Csm6-mediated RNA degradation. Therefore, Csm6 appears to be an accessory RNase that rescues type III-A immunity when DNA targets are difficult to detect or eliminate.
One fundamental difference between the Csm6-mediated response against phages and plasmids is that a host growth defect was only observed in the latter. We speculate that as a result of both the high concentration of phage genomes and the preferential transcription of these genomes during infection, the host cell contains a much higher proportion of phage transcripts 23 . It is reasonable to assume that the cOA degradation enzymes prevent accumulation of the inducer in most of the bacterial cytoplasm, except around its site of production where there is a local concentration of active Csm6 molecules. Thus, during the antiviral type III-A CRISPR response, the volume containing active Csm6 would be occupied mostly by phage RNA, and the impact on host transcripts (and thus growth) is less noticeable. Interestingly, Csm6 is similar to ribonuclease toxins in its indiscriminate RNA degradation. Indeed, HEPN domains are found in a wide range of predicted toxin-antitoxin modules and abortive infection systems in all three domains of life 35 . In contrast to the function sometimes ascribed to these systems, our data suggest that the role of Csm6 in immunity is not through the induction of host cell death but instead leads to temporary growth arrest. Although not found in our experimental system, there are possible scenarios whereby Csm6 activation could trigger cell death. For example, at very high phage concentrations, the Cas10-Csm complex might be unable to clear the virus, prolonging Csm6 activity to degrade total cellular RNA. This could kill the host, but would also prevent the release of functional viral particles, similar to programmed cell death pathways of eukaryotic cells 36 and abortive infection defence systems of prokaryotes 37 . Furthermore, there might be circumstances in which the DNase activity of Cas10 is completely compromised, such as base modifications in phage DNA that affect cleavage or anti-CRISPR proteins that could specifically inhibit the HD domain of Cas10. Future studies will determine whether global degradation of host transcripts by Csm6 can mediate abortive infection-like immunity.
Methods
Bacterial strains and growth conditions. S. aureus RN4220 30 was grown in tryptic soy broth (TSB) medium at 37 °C, supplemented with 10 µ g ml -1 of chloramphenicol or erythromycin for maintenance of plasmids pC194 38 or pE194 39 , respectively.
Molecular cloning. The plasmids with pCRISPR and harbouring either a gp43 spacer (pWJ191, pWJ241) or no spacer (pGG-BsaI-R) have been described elsewhere 23, 29 . The sequences of the oligonucleotides used in this study are provided in Supplementary Table 1 . The plasmids used in this study are shown in Supplementary Table 2 . The plasmid cloning strategies are shown in Supplementary  Table 3 . All pCRISPR plasmids contain one spacer flanked by two repeats.
Conjugation.
Conjugation was performed using filter mating as previously described 2 into recipients containing the specified pCRISPRs (pGG25, pGG-BsaI-R, pJTR111, pJTR135, pJTR138, pJTR175 or pJTR177). Pictures of colonies for Fig. 5d were obtained by imaging the plates using an Axygen Scientific GD1000 gel documentation system 24 h after plating.
Plasmid curing assay. Overnight RN4220 cultures carrying pTarget (pJTR162) and the specified pCRISPRs (pWJ191, pWJ241, pJTR125, pJTR147, pGG-BsaI-R) were diluted to an absorbance (A) of exactly 0.15 in TSB containing 10 µ g ml -1 of chloramphenicol. Where relevant, 200 µ g ml -1 of neomycin was added. aTc was added to a final concentration of either 7.5 ng ml -1 (low aTc condition) or 50 ng ml -1 (high aTc condition), and cells were isolated and plasmid extracted at the specified timepoints. A total of 300 ng of total plasmid was then linearized with the common single cutter BamHI-HF (NEB), and imaged by gel electrophoresis.
Growth curves. Triplicate overnight RN4220 cultures carrying pTarget and the specified pCRISPRs (pWJ191, pWJ241, pGG-BsaI-R, pJTR109, pJTR121, pJTR125) were diluted 1:100 in fresh TSB with 10 µ g ml -1 of chloramphenicol, and 10 µ g ml -1 of erythromycin where specified, and outgrown for 1 h. Cells were then diluted and normalized for A, moved to a 96-well plate in triplicate, and aTc was added to a final concentration of either 2.5 ng ml -1 (low aTc condition) or 12.5 ng ml -1 (high aTc condition). A 600 readings were then taken every 10 min using a microplate reader (TECAN Infinite 200 PRO). For measuring the c.f.u. from each well, plateau-phase cells from the end of the experiment were resuspended, serial diluted and spotted on TSB agar plates. Plates contained 10 µ g ml -1 of chloramphenicol when selecting for pCRISPR only or 10 µ g ml -1 of chloramphenicol and 10 µ g ml -1 of erythromycin when also selecting for pTarget. For the Cas10 HD domain targeting escaper growth curves, cells that recovered at the end of the experiment shown in Fig. 5a (cas10 HD cells grown in high aTc conditions) were streaked out, and single colonies were picked for a new growth experiment in the presence of high levels of aTc. To analyse these escapers, DNA was isolated, subjected to PCR using primers JTR390 and W1022, with the products being visualized by gel electrophoresis. PCR products (escapers 1-3) or isolated plasmid (escaper 4) were sent for Sanger sequencing to confirm the observed deletions.
RNA purification. For isolating RNA for pG0400 and pG0420 RNA-seq, 5 ml of S. aureus RN4220 cells at an A of 0.6 containing the relevant plasmid were spun down. For isolating RNA for Csm6-targeting RNA-seq, 20 ml of S. aureus RN4220 cells at an A of 0.15 were spun down at 0 min or 2 min after aTc addition. For both RNA-seq runs, cells were lysed in PBS with treatment with 1 mg ml -1 lysostaphin and 2 mg ml -1 lysozyme for 5 min, followed by the addition of 1% sarcosyl. For the Csm6-targeting RNA-seq, 2.5 µ g of Listeria seeligeri RNA was added at this stage. RNA was then purified using a Quick-RNA Miniprep Plus kit (Zymo Research). For northern blot analysis, 80 ml of a culture of S. aureus RN4220 cells (at an A of 0.15) were spun down and lysed as described above. The RNA was then isolated by resuspending the lysed cells in TRIzol (Thermo Fisher Scientific) and following the manufacturer's protocol of TRIzol.
RNA-seq of pG0400 and pG0420. RNA was isolated from cells harbouring pG0400 or pG0420 as described above, DNase treated (Invitrogen TURBO DNAfree kit according to the manufacturer's protocol) and rRNase depleted (Illumina Ribo-Zero rRNA Removal kit (Bacteria) according to the manufacturer's protocol). Library preparation was performed using a TruSeq Stranded mRNA kit (Illumina), and the sequencing was performed by Illumina MiSeq. Reads were aligned using STAR 40 v.2.5 to either pG0400 41 (GenBank reference KT780705) or S. aureus NCTC 8325 (GenBank reference CP000253), without normalization.
RNA-seq of pTarget using a spike RNA. In duplicate, overnight cultures of S. aureus RN4220 carrying pTarget and pCRISPRs containing cas10 HD and either csm6 or dcsm6 (pJTR109 or pJTR125) were diluted to an A 600 of exactly 0.15 in TSB. Cells were then collected for the 0 min timepoint. Then, aTc was added to a final concentration of 7.5 ng ml -1 (similar to the low concentration used for plasmid curing), and cells were collected after 2 min, quenching the reaction with cold TSB. RNA was then isolated as described above. At the cell lysis stage (after adding the TRI reagent of the Quick-RNA Miniprep Plus kit (Zymo Research)), an equal amount of purified L. seeligeri RNA was added to each sample, to be carried through the purification to allow absolute comparisons between the samples. Library preparation was then carried out as for pG0400 and pG0420 RNA-seq, and the samples were submitted to NextSeq (Illumina) sequencing at the Rockefeller University Genomics core (New York, USA). For the analysis, as described previously 42 , the normalization protocol relied on the number of spike reads mapping to the L. seeligeri genome (NC_013891.1). In the first round of read mapping, the reads for each sample were mapped to S. aureus using STAR aligner, with standard parameters except for allowing a maximum of one mismatch. The unmapped reads were then aligned to the L. seeligeri genome. Since each sample initially had the same number of L. seeligeri spike reads at the lysis stage, a scaling factor was calculated to make the number of L. seeligeri reads identical between the samples. This scaling factor was later used to normalize the reads mapping to the S. aureus chromosome or pTarget between samples. Then, for the second round of mapping, all reads were first aligned to L. seeligeri (to eliminate spike reads), and the remaining reads were mapped to either S. aureus or pTarget. The total assigned reads per gene was determined using featureCounts 43 with largestOverlap set to TRUE. The number of assigned reads to each gene was then normalized by multiplying with the previously calculated scaling factor, thus allowing absolute comparison between the number of assigned reads to a gene between different samples.
Northern blot analysis.
Overnight RN4220 cultures carrying pTarget and the specified pCRISPRs (pWJ191 or pWJ241) were diluted to an ODA of exactly 0.15 in TSB containing 10 µ g ml -1 of chloramphenicol. A volume (80 ml) of cells were collected at the 0 min timepoint. Then, aTc was added to a final concentration of 7.5 ng ml -1 , and 80 ml of cells were again collected after 2 min. RNA was isolated as described above. The RNA was separated on a 6% gel by polyacrylamide gel electrophoresis, and blotted onto nylon filters (Invitrogen BrightStar Plus) using a semi-dry blotting apparatus. The oligonucleotide probes were radiolabelled with γ -32 P-labelled ATP using PNK (NEB), and incubated with the nylon membranes overnight at 42 °C in the presence of 0.1 mg ml -1 salmon sperm DNA. The membranes were then visualized by phosphorimaging (Typhoon FLA 7000, GE Life Sciences). For assaying pTarget induction at low or high aTc concentrations, cells containing either pJTR162 or pE194 were isolated before or 2 min after adding 7.5 ng ml -1 or 50 ng ml -1 , respectively. The rest of the protocol was performed as described above.
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